January 12, 2022
RFA-DA-22-033 - Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
NOT-DA-21-089 - Notice of Change to RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)"
National Institute on Drug Abuse (NIDA)
The purpose of this notice is to alert potential applicants to updated eligibility language in Funding Opportunity Announcement (FOA) RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)". This change removes eligibility limiting language regarding allowable submissions.
The following modification has been made to RFA-DA-22-033:
Currently Reads:
Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
Federal Governments
Other
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions)are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement,are allowed.
Modified to Read (changes shown in bold italics):
Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
o Hispanic-serving Institutions
o Historically Black Colleges and Universities (HBCUs)
o Tribally Controlled Colleges and Universities (TCCUs)
o Alaska Native and Native Hawaiian Serving Institutions
o Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Governments
Other
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
All other aspects of this FOA remain unchanged.
Sheba K. Dunston, EdD, MPH, CHES
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1526
Email: Sheba.Dunston@nih.gov